on 31 Dec 2019
Last Applicant/ Owned by
ADVERUM BIOTECHNOLOGIES INC.
1035 O'Brien Drive, Suite AMenlo Park, CA 94025
US
Serial Number
1809887 filed on 16th Nov 2016
Correspondent Address
SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa
ONTARIO
CA
K1P5Y6
Vienna Information
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 21
One letterUne lettre
26 . 3 . 1
One triangleUn triangle
26 . 3 . 7
Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
24 . 17 . 1
Punctuation marksSignes de ponctuation
24 . 17 . 2
DotsPoints
Trademark usage description
pharmaceutical preparations including pharmaceutical preparations for the treatment of diseases or disorders10
1809887
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 15 on 20th Mar 2019 | Correspondence Created |
Submitted for opposition 12 on 03rd Dec 2018 | Extension of Time |
Submitted for opposition 87 on 15th Oct 2018 | Rep for Service Changed |
Submitted for opposition 48 on 15th Oct 2018 | Agent Changed |
Submitted for opposition 12 on 20th Apr 2018 | Extension of Time |
Submitted for opposition 22 on 05th Oct 2017 | Search Recorded |
Submitted for opposition 20 on 05th Oct 2017 | Examiner's First Report |
Submitted for opposition 31 on 18th Nov 2016 | Formalized |
Submitted for opposition 1 on 17th Nov 2016 | Created |
Submitted for opposition 30 on 16th Nov 2016 | Filed |